TLNC1 was previously known as linc01134, which has been demonstrated to promote the progression and metastasis, as well as confer oxaliplatin resistance in hepatocellular carcinoma (HCC) by several recent studies [16–19], indicating that this lncRNA plays vital roles in HCC. Here, LINC01134 is linked to hepatocellular carcinoma.